Minocycline Immunomodulates via Sonic Hedgehog Signaling and Apoptosis and Has Direct Potency Against Drug-Resistant Tuberculosis. (28th December 2018)

• Record Type: Journal Article
• Authors: Deshpande, Devyani; Pasipanodya, Jotam G; Srivastava, Shashikant; Martin, Katherine R; Athale, Shruti; van Zyl, Johanna; Antiabong, John; Koeuth, Thearith; Lee, Pooi S; Dheda, Keertan; Gumbo, Tawanda
• Is Part Of: Journal of infectious diseases. Volume 219:Number 6(2019)
• Page Start: 975
• Page End: 985
• Publication Date: 2018-12-28
• Subjects: Smac/DIABLO -- caspase 3 -- PTCH1 -- GLI1 -- lung remodeling -- host-directed therapy; Communicable diseases -- Periodicals; Diseases -- Causes and theories of causation -- Periodicals; Medicine -- Periodicals; Communicable Diseases -- Periodicals; Electronic journals; 616.9
• DOI: 10.1093/infdis/jiy587
• Languages: English
• ISSNs: 0022-1899

Abstract

Abstract : We are running out of treatments for multidrug-resistant tuberculosis. Minocycline, an old and safe antibiotic, was highly potent against Mycobacterium tuberculosis in preclinical models. It potentiated bacterial killing by the immune system and promoted immune pathways associated with healing. Abstract: Drug-resistant tuberculosis represents a global emergency, requiring new drugs. We found that minocycline was highly potent in laboratory strains of Mycobacterium tuberculosis and that 30 drug-susceptible and multidrug/extensively drug-resistant clinical strains were susceptible to clinically achievable concentrations. In the hollow fiber system model, lung concentration-time profiles of 7 mg/kg/day human-equivalent minocycline dose achieved bacterial kill rates equivalent to those of first-line antituberculosis agents. Minocycline killed extracellular bacilli directly. Minocycline also killed intracellular bacilli indirectly, via concentration-dependent granzyme A–driven apoptosis. Moreover, minocycline demonstrated dose-dependent antiinflammatory activity and downregulation of extracellular matrix-based remodeling pathways and, thus, could protect patients from tuberculosis immunopathology. In RNA sequencing of repetitive samples from the hollow fiber system and in independent protein abundance experiments, minocycline demonstrated dose-dependent inhibition of sonic hedgehog–patched–gli signaling. These findings have implications for improved lung remodeling and for dual immunomodulation and direct microbial kill-based treatment shortening regimens for drug-susceptible and drug-resistant latent and active M. tuberculosis infection.